The specialist will provide business continuity for territory gaps while leading high-priority commercial initiatives for hemolytic anemia treatments. They are responsible for strengthening customer engagement, improving patient identification pathways, and delivering scientific education to healthcare professionals.
Own the territory business plan and raise awareness of Pyruvate Kinase Deficiency and Thalassemia to support earlier diagnosis and treatment initiation with Pyrukynd and Aqvesme. Build customer relationships, coordinate with internal field teams, and achieve sales targets while ensuring compliant customer engagement and adjusting strategies based on performance.
Own the territory commercial plan, raise awareness and support earlier diagnosis of Pyruvate Kinase Deficiency and Thalassemia, and drive appropriate initiation of Pyrukynd and Aqvesme in adult patients. Collaborate with field, medical affairs, market access, and marketing teams; build customer relationships; meet sales targets; and ensure compliant customer engagement.
The Hemolytic Anemia Specialist is responsible for driving awareness and product adoption for Pyruvate Kinase Deficiency and Thalassemia treatments within their assigned territory. They will develop integrated business plans, manage key customer relationships, and collaborate with cross-functional teams to achieve revenue objectives.
The Associate Director will lead the development and execution of value, access, and pricing strategies for the Agios portfolio in Europe and the GCC. This role involves collaborating with internal teams and external distributors to secure patient access through effective negotiations and value-based storytelling.
The AD, Field Access Manager ensures patient access to therapies by navigating payer coverage and specialty pharmacy pathways. They serve as a regional expert to remove access barriers through collaboration with HCPs, payers, and internal teams.
